Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Ronot M, Bouattour M, Wassermann J, Bruno O, Dreyer C, Larroque B, et al. Alternative response criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib. Oncologist. 2014;19:394–402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.

Article  PubMed  Google Scholar 

Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005;434:913–7.

Article  CAS  PubMed  Google Scholar 

Schreiber V, Dantzer F, Ame JC, de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 2006;7:517–28.

Article  CAS  PubMed  Google Scholar 

San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229–57.

Article  CAS  PubMed  Google Scholar 

Sasaki M, Lange J, Keeney S. Genome destabilization by homologous recombination in the germ line. Nat Rev Mol Cell Biol. 2010;11:182–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Soto JA, Deng C-X. PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int J Med Sci. 2006;3:117–23.

Article  PubMed  PubMed Central  Google Scholar 

Murai J, Huang SN, Das BB, Renaud A, Zhang Y, Doroshow JH, et al. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Res. 2012;72:5588–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009;361:123–34.

Article  CAS  PubMed  Google Scholar 

Gerring SL, Spencer F, Hieter P. The CHL 1 (CTF 1) gene product of Saccharomyces cerevisiae is important for chromosome transmission and normal cell cycle progression in G2/M. EMBO J. 1990;9:4347–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spencer F, Gerring SL, Connelly C, Hieter P. Mitotic chromosome transmission fidelity mutants in Saccharomyces cerevisiae. Genetics. 1990;124:237–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Lelij P, Chrzanowska KH, Godthelp BC, Rooimans MA, Oostra AB, Stumm M, et al. Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChlR1. Am J Hum Genet. 2010;86:262–6.

Article  PubMed  PubMed Central  Google Scholar 

van Schie JJM, Faramarz A, Balk JA, Stewart GS, Cantelli E, Oostra AB, et al. Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion. Nat Commun. 2020;11:4287.

Article  PubMed  PubMed Central  Google Scholar 

Jegadesan NK, Branzei D. DDX11 loss causes replication stress and pharmacologically exploitable DNA repair defects. Proc Natl Acad Sci USA. 2021;118:e2024258118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharya C, Wang X, Becker D. The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas. Mol Cancer. 2012;11:82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sui Y, Liu J, Zhang J, Zheng Z, Wang Z, Jia Z, et al. Expression and gene regulation network of adenosine receptor A2B in Lung Adenocarcinoma: a potential diagnostic and prognostic biomarker. Front Mol Biosci. 2021;8:663011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calì F, Bharti SK, Di Perna R, Brosh RM, Pisani FM. Tim/Timeless, a member of the replication fork protection complex, operates with the Warsaw breakage syndrome DNA helicase DDX11 in the same fork recovery pathway. Nucleic Acids Res. 2016;44:705–17.

Article  PubMed  Google Scholar 

Cortone G, Zheng G, Pensieri P, Chiappetta V, Tatè R, Malacaria E, et al. Interaction of the Warsaw breakage syndrome DNA helicase DDX11 with the replication fork-protection factor Timeless promotes sister chromatid cohesion. PLoS Genet. 2018;14:e1007622.

Article  PubMed  PubMed Central  Google Scholar 

Lerner LK, Holzer S, Kilkenny ML, Šviković S, Murat P, Schiavone D, et al. Timeless couples G-quadruplex detection with processing by DDX11 helicase during DNA replication. EMBO J. 2020;39:e104185.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abe T, Ooka M, Kawasumi R, Miyata K, Takata M, Hirota K, et al. Warsaw breakage syndrome DDX11 helicase acts jointly with RAD17 in the repair of bulky lesions and replication through abasic sites. Proc Natl Acad Sci USA. 2018;115:8412–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stoepker C, Faramarz A, Rooimans MA, van Mil SE, Balk JA, Velleuer E, et al. DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity. DNA Repair. 2015;26:54–64.

Article  CAS  PubMed  Google Scholar 

Inoue A, Li T, Roby SK, Valentine MB, Inoue M, Boyd K, et al. Loss of ChlR1 helicase in mouse causes lethality due to the accumulation of aneuploid cells generated by cohesion defects and placental malformation. Cell Cycle. 2007;6:1646–54.

Article  CAS  PubMed  Google Scholar 

Rossi F, Helbling-Leclerc A, Kawasumi R, Jegadesan NK, Xu X, Devulder P, et al. SMC5/6 acts jointly with Fanconi anemia factors to support DNA repair and genome stability. EMBO Rep. 2020;21:e48222.

Article  CAS  PubMed  Google Scholar 

Olivieri M, Cho T, Álvarez-Quilón A, Li K, Schellenberg MJ, Zimmermann M, et al. A Genetic Map of the Response to DNA Damage in Human Cells. Cell. 2020;182:481–96.e21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gunn A, Stark JM. I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks. Methods Mol Biol. 2012;920:379–91.

Article  CAS  PubMed  Google Scholar 

Luo K, Li L, Li Y, Wu C, Yin Y, Chen Y, et al. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination. Genes Dev. 2016;30:2581–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khanna KK, Lavin MF, Jackson SP, Mulhern TD. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 2001;8:1052–65.

Article  CAS  PubMed  Google Scholar 

Kastan MB, Lim DS. The many substrates and functions of ATM. Nat Rev Mol Cell Biol. 2000;1:179–86.

Article  CAS  PubMed  Google Scholar 

Wang C, Tang H, Geng A, Dai B, Zhang H, Sun X, et al. Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors. Proc Natl Acad Sci USA. 2020;117:26356–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Liu L, Liu X, Xu P, Hu Q, Yu Y. The role of upregulated DDX11 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. J Cancer. 2019;10:4208–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirota Y, Lahti JM. Characterization of the enzymatic activity of hChlR1, a novel human DNA helicase. Nucleic Acids Res. 2000;28:917–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Motegi A, Masutani M, Yoshioka K-I, Bessho T. Aberrations in DNA repair pathways in cancer and therapeutic significances. Semin Cancer Biol. 2019;58:29–46.

Article  CAS  PubMed  Google Scholar 

Brown JS, O’Carrigan B, Jackson SP, Yap TA. Targeting DNA repair in cancer: beyond PARP Inhibitors. Cancer Discov. 2017;7:20–37.

Article  CAS